Company / Tangible Book Value per Share
CG Oncology, Inc. Tangible Book Value per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$9.60
FY2025
5-year range
-$28.42 / $11.73
FY2023-FY2025
Trend
-18.2%
vs FY2024
Sector context
#51 of 209
Health Care
What the data says
CG Oncology, Inc.'s tangible book value per share of $9.60 is higher than 76% of companies in the Health Care sector (FY2025). Improved from $-28.42 to $9.60 over the past 2 years.
Based on SEC 10-K filings.
9.60 in FY2025. Top quartile in the Health Care sector.
Improved from $-28.42 to $9.60 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 209This company $9.60 Sector average $93.31
▼
-89.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 18.2% year-over-year.
- Ranks #51 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.60 | -18.2% |
| FY2024 | $11.73 | +141.3% |
| FY2023 | -$28.42 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026